Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 301–350 of 606 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00526656	Sunitinib in Treating Patients With Locally Advanced Bladder Cancer	completed	Phase 2	9	Case Comprehensive Cancer CenterOTHER	1	Apr 16, 2019	clinicaltrials
NCT02109328	Alisertib in Chemotherapy-pretreated Urothelial Cancer	completed	Phase 2	22	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Apr 11, 2019	clinicaltrials